Frequency of MYD88 L256P mutation and its correlation with clinico-hematological profile in mature B-cell neoplasm | Zendy

Raja Shekhar | Zendy; Shano Naseem | Zendy; Jogeshwar Binota | Zendy; Neelam Varma | Zendy; Pankaj Malhotra | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Frequency of MYD88 L256P mutation and its correlation with clinico-hematological profile in mature B-cell neoplasm

Author(s) -

Raja Shekhar,

Shano Naseem,

Jogeshwar Binota,

Neelam Varma,

Pankaj Malhotra

Publication year - 2020

Publication title -

hematology/oncology and stem cell therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.666

H-Index - 22

eISSN - 1658-3876

pISSN - 2589-0646

DOI - 10.1016/j.hemonc.2020.10.003

Subject(s) - neoplasm , mutation , correlation , myeloproliferative neoplasm , biology , medicine , cancer research , genetics , bone marrow , mathematics , gene , geometry , myelofibrosis

B-cell neoplasms are clonal tumors of B cells at various stages of maturation, including diffuse large B-cell lymphoma (DLBCL), chronic lymphocytic lymphoma (CLL), Burkitt lymphoma (BL), lymphoplasmacytic lymphoma (LPL)/Waldenström's macroglobulinemia (WM), splenic marginal zone lymphoma (SMZL), nodal marginal zone lymphoma (NMZL), mantle cell lymphoma (MCL), follicular lymphoma (FL), and hairy cell leukemia (HCL). In this study, we analyzed the frequency of MYD88 L265P mutation and its correlation with clinico-hematological profile in mature B-cell neoplasms.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research